Nisa Investment Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,970
Closed -$207K 2836
2023
Q4
$207K Buy
6,970
+540
+8% +$10.8K ﹤0.01% 1269
2023
Q3
$102K Sell
6,430
-18
-0.3% -$299 ﹤0.01% 1496
2023
Q2
$122K Buy
6,448
+848
+15% +$10K ﹤0.01% 1463
2023
Q1
$22K Sell
5,600
-4,890
-47% -$20.8K ﹤0.01% 1987
2022
Q4
$52K Sell
10,490
-64
-0.6% -$347 ﹤0.01% 1758
2022
Q3
$63K Buy
10,554
+164
+2% +$865 ﹤0.01% 1661
2022
Q2
$47K Buy
10,390
+5,600
+117% +$24.3K ﹤0.01% 1753
2022
Q1
$23K Sell
4,790
-4,470
-48% -$24.7K ﹤0.01% 2027
2021
Q4
$52K Sell
9,260
-3,470
-27% -$21.6K ﹤0.01% 1724
2021
Q3
$72 Hold
12,730
﹤0.01% 1834
2021
Q2
$84 Hold
12,730
﹤0.01% 1782
2021
Q1
$103 Hold
12,730
﹤0.01% 1736
2020
Q4
$82K Buy
12,730
+9,700
+320% +$56.6K ﹤0.01% 1818
2020
Q3
$11K Buy
3,030
+990
+49% +$4K ﹤0.01% 2109
2020
Q2
$9K Buy
2,040
+440
+28% +$1.87K ﹤0.01% 1950
2020
Q1
$5K Hold
1,600
﹤0.01% 1959
2019
Q4
$8K Hold
1,600
﹤0.01% 1879
2019
Q3
$4K Hold
1,600
﹤0.01% 1942
2019
Q2
$3K Hold
1,600
﹤0.01% 1958
2019
Q1
$4K Sell
1,600
-43,700
-96% -$189K ﹤0.01% 1954
2018
Q4
$217K Buy
45,300
+44,565
+6,063% +$270K ﹤0.01% 1220
2018
Q3
$7K Buy
735
+60
+9% +$577 ﹤0.01% 1820
2018
Q2
$7K Hold
675
﹤0.01% 1805
2018
Q1
$7K Sell
675
-1,125
-63% -$11.1K ﹤0.01% 1748
2017
Q4
$12K Buy
1,800
+460
+34% +$2.84K ﹤0.01% 1704
2017
Q3
$10K Hold
1,340
﹤0.01% 1750
2017
Q2
$10K Sell
1,340
-660
-33% -$3.02K ﹤0.01% 1730
2017
Q1
$8K Buy
+2,000
New +$5.84K ﹤0.01% 1739

Other funds holding IMGN

Nisa Investment Advisors's IMGN Position: Q1 2024 in Review

Nisa Investment Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 6,970 shares — an estimated $207K sold.

Nisa Investment Advisors first reported a position in IMGN in Q1 2017 and held it in 28 quarters. The position peaked at $217K in Q4 2018. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Nisa Investment Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 6,970 Immunogen Inc shares in Q1 2024, an estimated $207K.
  • Nisa Investment Advisors first reported a position in Immunogen Inc in Q1 2017 and held it in 28 quarters.
  • Nisa Investment Advisors's Immunogen Inc position peaked at $217K in Q4 2018.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Nisa Investment Advisors's 13F filing for Q1 2024, filed 2 May 2024.